Published by Michele Maatouk on 10th May 2024
(Sharecast News) - Shares of US biotech firm Novavax rocketed on Friday after it signed a $1.2bn licensing agreement with French pharmaceutical group Sanofi to commercialise its Covid-19 vaccine from next year.
URL: http://www.digitallook.com/dl/news/story/34284223/...